세계의 세포 및 유전자 치료 바이오 분석 시험 서비스 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 시험 유형별, 제품 유형별, 개발 단계별, 적응증별, 지역별, 경쟁별(2020-2030년)

Cell & Gene Therapy Bioanalytical Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Product Type, By Stage of Development, By Indication, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,324,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,730,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,244,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 세포 및 유전자 치료 바이오 분석 시험 서비스 시장은 2024년에는 5억 2,326만 달러로 평가되었고, 2030년에는 8억 7,029만 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR은 8.85%로 성장할 전망입니다.

세포 및 유전자 치료 분야의 확장은 개인 맞춤형 표적 치료법을 제공함으로써 유전 및 만성 질환에 대한 치료 접근법을 혁신하고 있습니다. 이러한 치료법이 연구 단계에서 상용화로 발전함에 따라 정확하고 규정을 준수하는 바이오 분석 테스트 서비스에 대한 수요가 크게 증가하고 있습니다. 이러한 서비스는 진화하는 규제 기대치에 맞춰 안전성, 유효성 및 품질을 보장하는 데 매우 중요합니다. 지원 자금, 기술 혁신, 치료 파이프라인의 확대로 시장 개발이 가속화되고 있으며, 맞춤형 치료 솔루션에 대한 업계의 관심이 높아지면서 세포 및 유전자 치료 수명 주기에서 바이오 분석 시험의 역할이 계속 높아지고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모(2024년)	5억 2,326만 달러
시장 규모(2030년)	8억 7,029만 달러
CAGR(2025-2030년)	8.85%
급성장 부문	종양학
최대 시장	북미

시장 성장 촉진요인

세포 및 유전자 치료 연구 및 개발에 대한 투자 증가

주요 시장 과제

규제 문제

주요 시장 동향

기술 발전

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 세포 및 유전자 치료 바이오 분석 시험 서비스 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 시험 유형별(생체 이용률 및 생물학적 동등성 연구, 약동학, 약역학, 기타 시험 유형)
  • 제품 유형별(유전자 치료, 유전자 변형 세포 치료, 세포 치료)
  • 개발 단계별(비임상, 임상)
  • 적응증별(종양학, 감염증, 신경질환, 희귀질환, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 세포 및 유전자 치료 바이오 분석 시험 서비스 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 세포 및 유전자 치료 바이오 분석 시험 서비스 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 세포 및 유전자 치료 바이오 분석 시험 서비스 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 세포 및 유전자 치료 바이오 분석 시험 서비스 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 세포 및 유전자 치료 바이오 분석 시험 서비스 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 합병 및 인수
• 제품 개발
• 최근 동향

제13장 세계의 세포 및 유전자 치료 바이오 분석 시험 서비스 시장 :SWOT 분석

제14장 경쟁 구도

• BioAgilytix Labs Inc.
• KCAS Bioanalytical & Biomarker Services
• IQVIA, Inc.
• Laboratory Corporation of America Holdings
• Thermo Fisher Scientific Inc.
• Prolytix pvt ltd
• Pharmaron Biologics(UK) Ltd
• Charles River Laboratories International, Inc.
• Syneos Health Ltd
• Intertek Group Plc

제15장 전략적 제안

제16장 기업 소개와 면책사항

HBR

영문 목차

영문목차

The Global Cell & Gene Therapy Bioanalytical Testing Services Market was valued at USD 523.26 million in 2024 and is expected to reach USD 870.29 million by 2030, growing at a CAGR of 8.85% during the forecast period. The expanding field of cell and gene therapy is revolutionizing treatment approaches for genetic and chronic diseases by offering personalized, targeted therapies. As these therapies progress from research to commercialization, the demand for precise and compliant bioanalytical testing services is growing significantly. These services are critical for ensuring safety, efficacy, and quality in line with evolving regulatory expectations. Supportive funding, technological innovations, and the expanding therapeutic pipeline are accelerating market development, while growing industry emphasis on tailored treatment solutions continues to elevate the role of bioanalytical testing in the cell and gene therapy lifecycle.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 523.26 Million
Market Size 2030	USD 870.29 Million
CAGR 2025-2030	8.85%
Fastest Growing Segment	Oncology
Largest Market	North America

Key Market Drivers

Increasing Investment in Cell and Gene Therapy Research and Development

Recent breakthroughs in cell and gene therapy have opened new possibilities for treating diseases previously deemed untreatable. These treatments work by altering patients' own cells or genes to address conditions such as cancer, autoimmune disorders, and genetic abnormalities. As the clinical potential of these therapies becomes more evident, global investment in research and development has increased rapidly. Bioanalytical testing services play an essential role in this growth by ensuring product safety, efficacy, and consistency. Notably, in April 2023, the California Institute for Regenerative Medicine committed USD 89.0 million toward advancing gene and stem cell research, exemplifying the growing commitment to innovation in this space.

Key Market Challenges

Regulatory Challenges

Navigating regulatory frameworks remains one of the most pressing challenges in the cell and gene therapy bioanalytical testing market. Regulatory agencies are continuously updating standards to ensure patient safety while accommodating rapid technological advances. This dynamic landscape makes compliance a complex and time-consuming process. Companies often face delays and increased costs when attempting to align with these evolving guidelines, which can hinder the pace of therapy development and market entry. Meeting global regulatory expectations while innovating at speed demands significant investment and specialized expertise.

Key Market Trends

Technological Advancements

As cell and gene therapies reshape modern medicine, the bioanalytical testing segment is advancing rapidly to meet new analytical demands. A major trend is the integration of single-cell analysis technologies, including single-cell RNA sequencing and proteomics, which allow deeper insights into cellular responses and therapeutic outcomes. These methods address the limitations of traditional bulk analysis by revealing intercellular variability. Another transformative trend is the adoption of CRISPR-Cas9, a powerful gene-editing tool that demands specialized testing protocols to evaluate gene function and detect potential off-target effects. Furthermore, the deployment of state-of-the-art instrumentation has enhanced the precision and speed of testing processes, enabling faster and more accurate evaluation of complex therapies and supporting the broader growth of the market.

Key Market Players

• BioAgilytix Labs Inc.
• KCAS Bioanalytical & Biomarker Services
• IQVIA, Inc.
• Laboratory Corporation of America Holdings
• Thermo Fisher Scientific Inc.
• Prolytix pvt ltd
• Pharmaron Biologics (UK) Ltd
• Charles River Laboratories International, Inc.
• Syneos Health Ltd
• Intertek Group Plc

Report Scope:

In this report, the Global Cell & Gene Therapy Bioanalytical Testing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type:

• Bioavailability & Bioequivalence Studies
• Pharmacokinetics
• Pharmacodynamics
• Other test type

Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type:

• Gene Therapy
• Gene-Modified Cell Therapy
• Cell Therapy

Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development:

• Non-Clinical
• Clinical

Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication:

• Oncology
• Infectious Diseases
• Neurological disorders
• Rare Diseases
• Others

Cell & Gene Therapy Bioanalytical Testing Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell & Gene Therapy Bioanalytical Testing Services Market.

Available Customizations:

Global Cell & Gene Therapy Bioanalytical Testing Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test Type)
  • 5.2.2. By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy)
  • 5.2.3. By Stage of Development (Non-Clinical, Clinical)
  • 5.2.4. By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Product Type
  • 6.2.3. By Stage of Development
  • 6.2.4. By Indication
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Stage of Development
      • 6.3.1.2.4. By Indication
  • 6.3.2. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Stage of Development
      • 6.3.2.2.4. By Indication
  • 6.3.3. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Stage of Development
      • 6.3.3.2.4. By Indication

7. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Product Type
  • 7.2.3. By Stage of Development
  • 7.2.4. By Indication
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Stage of Development
      • 7.3.1.2.4. By Indication
  • 7.3.2. United Kingdom Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Stage of Development
      • 7.3.2.2.4. By Indication
  • 7.3.3. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Stage of Development
      • 7.3.3.2.4. By Indication
  • 7.3.4. France Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Stage of Development
      • 7.3.4.2.4. By Indication
  • 7.3.5. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Stage of Development
      • 7.3.5.2.4. By Indication

8. Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Product Type
  • 8.2.3. By Stage of Development
  • 8.2.4. By Indication
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Stage of Development
      • 8.3.1.2.4. By Indication
  • 8.3.2. India Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Stage of Development
      • 8.3.2.2.4. By Indication
  • 8.3.3. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Stage of Development
      • 8.3.3.2.4. By Indication
  • 8.3.4. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Stage of Development
      • 8.3.4.2.4. By Indication
  • 8.3.5. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Stage of Development
      • 8.3.5.2.4. By Indication

9. South America Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Product Type
  • 9.2.3. By Stage of Development
  • 9.2.4. By Indication
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Stage of Development
      • 9.3.1.2.4. By Indication
  • 9.3.2. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Stage of Development
      • 9.3.2.2.4. By Indication
  • 9.3.3. Colombia Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Stage of Development
      • 9.3.3.2.4. By Indication

10. Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Product Type
  • 10.2.3. By Stage of Development
  • 10.2.4. By Indication
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Stage of Development
      • 10.3.1.2.4. By Indication
  • 10.3.2. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Stage of Development
      • 10.3.2.2.4. By Indication
  • 10.3.3. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Stage of Development
      • 10.3.3.2.4. By Indication

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Cell & Gene Therapy Bioanalytical Testing Services Market: SWOT Analysis

14. Competitive Landscape

• 14.1. BioAgilytix Labs Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. KCAS Bioanalytical & Biomarker Services
• 14.3. IQVIA, Inc.
• 14.4. Laboratory Corporation of America Holdings
• 14.5. Thermo Fisher Scientific Inc.
• 14.6. Prolytix pvt ltd
• 14.7. Pharmaron Biologics (UK) Ltd
• 14.8. Charles River Laboratories International, Inc.
• 14.9. Syneos Health Ltd
• 14.10. Intertek Group Plc

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료